Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pimecrolimus vs mometasone cream for childhood vitiligo
IRCT20230307057646N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jul 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pimecrolimus and mometasone in Vitiligo (2 arms), sponsored by Isfahan University of Medical Sciences. Started Jul 2023; status: completed.
02
Drugs
pimecrolimusmometasone
03
Conditions
Vitiligo
Beyond the preview
Go deeper on IRCT20230307057646N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230307057646N1.